Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin B Davis

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2017
ELISA for Monitoring Nerve Growth FactorJustin B Davis
Expert Review of Proteomics|July 30, 2019
Proteomics for cancer drug designAmanda Haymond, Justin B Davis, Virginia Espina
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2020
Reverse Phase Protein ArraysJustin B Davis, Sydney Andes, Virginia Espina
Expert Review of Proteomics|October 30, 2024
Protein biomarkers for subtyping breast cancer and implications for future research: a 2024 updateClaudius Mueller, Justin B Davis, Virginia Espina
Advances in Experimental Medicine and Biology|December 11, 2019
Combining the "Sibling Technologies" of Laser Capture Microdissection and Reverse Phase Protein MicroarraysClaudius Mueller, Justin B Davis, Lance A Liotta
Expert Review of Proteomics|December 23, 2017
Protein biomarkers for subtyping breast cancer and implications for future researchClaudius Mueller, Amanda Haymond, Justin B Davis, et al.
Heliyon|June 7, 2018
Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathwayJustin B Davis, Valerie Calvert, Steven Roberts, et al.
MMWR. Morbidity and Mortality Weekly Report|July 24, 2020
Notes from the Field: Effects of the COVID-19 Response on Tuberculosis Prevention and Control Efforts - United States, March-April 2020Ann M Cronin, Shanica Railey, Diana Fortune, et al.
Scientific Reports|November 24, 2019
A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistanceJustin B Davis, Sreshta S Krishna, Ryan Abi Jomaa, et al.
NPJ Precision Oncology|September 14, 2024
Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancerLaura E Johnston, Jamie Randall, Safae Chouraichi, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|May 15, 2017
ELISA for Monitoring Nerve Growth FactorJustin B Davis
Expert Review of Proteomics|July 30, 2019
Proteomics for cancer drug designAmanda Haymond, Justin B Davis, Virginia Espina
Methods in Molecular Biology (Clifton, N.J.)|November 25, 2020
Reverse Phase Protein ArraysJustin B Davis, Sydney Andes, Virginia Espina
Expert Review of Proteomics|October 30, 2024
Protein biomarkers for subtyping breast cancer and implications for future research: a 2024 updateClaudius Mueller, Justin B Davis, Virginia Espina
Advances in Experimental Medicine and Biology|December 11, 2019
Combining the "Sibling Technologies" of Laser Capture Microdissection and Reverse Phase Protein MicroarraysClaudius Mueller, Justin B Davis, Lance A Liotta
Expert Review of Proteomics|December 23, 2017
Protein biomarkers for subtyping breast cancer and implications for future researchClaudius Mueller, Amanda Haymond, Justin B Davis, et al.
Heliyon|June 7, 2018
Induction of nerve growth factor by phorbol 12-myristate 13-acetate is dependent upon the mitogen activated protein kinase pathwayJustin B Davis, Valerie Calvert, Steven Roberts, et al.
MMWR. Morbidity and Mortality Weekly Report|July 24, 2020
Notes from the Field: Effects of the COVID-19 Response on Tuberculosis Prevention and Control Efforts - United States, March-April 2020Ann M Cronin, Shanica Railey, Diana Fortune, et al.
Scientific Reports|November 24, 2019
A new model isolates glioblastoma clonal interactions and reveals unexpected modes for regulating motility, proliferation, and drug resistanceJustin B Davis, Sreshta S Krishna, Ryan Abi Jomaa, et al.
NPJ Precision Oncology|September 14, 2024
Proteomics based selection achieves complete response to HER2 therapy in HER2 IHC 0 breast cancerLaura E Johnston, Jamie Randall, Safae Chouraichi, et al.
Pageof 1